PROGRAM CANCER AGAINST ITSELF (Class 99)

The trademark application number 8066859 is currently marked as "New Application" in the official trademark registry.

The trademark application number 8066859 is owned by Earli Inc..

Trademark application number 8066859 is filed under Class 99, which relates to the specified goods and services.

Trademark application number 8066859 relates to "[CLASS : 5] Products for the prevention of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; products for the detection of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; products for the localization of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for localization of cancer; products for the therapy of cancer in humans, namely, pharmaceutical products to express a treatment agent for treating cancer; products for the prevention of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; products for the detection of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; products for the therapy of cancer in animals, namely, pharmaceutical products to express a treatment agent for treating cancer. [CLASS : 44] Medical services for the prevention of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; medical services for the detection of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; medical services for the localization of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for the localization of cancer; medical services for the therapy of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for treating cancer; medical services for the prevention of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; medical services for the detection of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; medical services for the therapy of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for the treatment of cancer.".